These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7545684

  • 1. Suramin inhibits C6 glioma-induced angiogenesis in vitro.
    Coomber BL.
    J Cell Biochem; 1995 Jun; 58(2):199-207. PubMed ID: 7545684
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F, Goto K, Weindel K, Folkman J.
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [Abstract] [Full Text] [Related]

  • 3. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
    Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S.
    Cancer Res; 1994 May 15; 54(10):2654-60. PubMed ID: 7513254
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B.
    Invest Ophthalmol Vis Sci; 1997 Apr 15; 38(5):817-23. PubMed ID: 9112976
    [Abstract] [Full Text] [Related]

  • 5. Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro.
    Gajdusek CM, Luo Z, Mayberg MR.
    J Cell Physiol; 1993 Oct 15; 157(1):133-44. PubMed ID: 7691833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells.
    Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP.
    Exp Cell Res; 1997 Sep 15; 235(2):403-12. PubMed ID: 9299165
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibronectin fragments released from phorbol ester-stimulated pulmonary artery endothelial cell monolayers promote neutrophil chemotaxis.
    Odekon LE, Frewin MB, Del Vecchio P, Saba TM, Gudewicz PW.
    Immunology; 1991 Sep 15; 74(1):114-20. PubMed ID: 1937565
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.
    Barthomeuf C, Lamy S, Blanchette M, Boivin D, Gingras D, Béliveau R.
    Free Radic Biol Med; 2006 Feb 15; 40(4):581-90. PubMed ID: 16458188
    [Abstract] [Full Text] [Related]

  • 19. Schwann cell-conditioned medium inhibits angiogenesis.
    Huang D, Rutkowski JL, Brodeur GM, Chou PM, Kwiatkowski JL, Babbo A, Cohn SL.
    Cancer Res; 2000 Nov 01; 60(21):5966-71. PubMed ID: 11085514
    [Abstract] [Full Text] [Related]

  • 20. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.
    Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg WD.
    J Pharmacol Exp Ther; 2000 Jan 01; 292(1):31-7. PubMed ID: 10604929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.